Literature DB >> 17123322

Single nucleotide polymorphisms of tumor necrosis factor-alpha and the susceptibility to bronchopulmonary dysplasia.

Sonya S Strassberg1, Ioana A Cristea, Dajun Qian, Lance A Parton.   

Abstract

Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease of infancy. A "New" BPD has been characterized in preterm infants that may begin in utero, and then progress post-natally, resulting in arrested lung development and alveolar hypoplasia. Foundations for this "New" BPD may be derived from pro-inflammatory genes including tumor necrosis factor-alpha (TNFalpha). The hypothesis of the current study is that single nucleotide polymorphisms (SNPs) of the pro-inflammatory TNFalpha gene place preterm infants at increased risk for BPD. Preterm infants (105 in number) with birthweights <or=1 kg, who survived to at least 36 weeks postmenstrual age (PMA) or discharge were enrolled into this study. They were stratified for BPD according to their need for supplemental oxygen at 28 days and at 36 weeks PMA (non-, mild-, moderate-, or severe-BPD). DNA was extracted from these infants and subjected to analyses for the TNFalpha SNPs: -1,031, -863, -857, -308, and -238. The PHASE software (version 2.1) was used to reconstruct haplotypes and estimate their frequencies within the study population. Differences in birth weight (P < 0.001) and gestational age (P < 0.001), but not in racial distribution between the groups were found. Haplotype-specific analysis revealed no significant association between BPD severity and any of the 5-marker common haplotypes with 10 or more copies in this study population. Additionally, no significant association was observed in any three SNP haplotypes at -1,031, -863, and -857, and two SNP haplotypes at -308 and -238. We observed no association between BPD severity and the five TNFalpha SNPs investigated. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17123322     DOI: 10.1002/ppul.20526

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  11 in total

Review 1.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 2.  Genetics of bronchopulmonary dysplasia in the age of genomics.

Authors:  Pascal M Lavoie; Marie-Pierre Dubé
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

Review 3.  Genetic predisposition to bronchopulmonary dysplasia.

Authors:  Charitharth Vivek Lal; Namasivayam Ambalavanan
Journal:  Semin Perinatol       Date:  2015-10-23       Impact factor: 3.300

Review 4.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

5.  Genetic associations of surfactant protein D and angiotensin-converting enzyme with lung disease in preterm neonates.

Authors:  K K Ryckman; J M Dagle; K Kelsey; A M Momany; J C Murray
Journal:  J Perinatol       Date:  2011-09-29       Impact factor: 2.521

Review 6.  Progress in understanding the genetics of bronchopulmonary dysplasia.

Authors:  Gary M Shaw; Hugh M O'Brodovich
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

7.  Mechanisms of bronchopulmonary dysplasia.

Authors:  Antonia P Popova
Journal:  J Cell Commun Signal       Date:  2013-01-20       Impact factor: 5.782

8.  A study of genes encoding cytokines (IL6, IL10, TNF), cytokine receptors (IL6R, IL6ST), and glucocorticoid receptor (NR3C1) and susceptibility to bronchopulmonary dysplasia.

Authors:  Johanna M Huusko; Minna K Karjalainen; Mari Mahlman; Ritva Haataja; M Anneli Kari; Sture Andersson; Gergely Toldi; Outi Tammela; Mika Rämet; Pascal M Lavoie; Mikko Hallman
Journal:  BMC Med Genet       Date:  2014-11-01       Impact factor: 2.103

Review 9.  Antioxidant strategies and respiratory disease of the preterm newborn: an update.

Authors:  Chiara Poggi; Carlo Dani
Journal:  Oxid Med Cell Longev       Date:  2014-04-07       Impact factor: 6.543

10.  The significance of IL-1β +3953C>T, IL-6 -174G>C and -596G>A, TNF-α -308G>A gene polymorphisms and 86 bp variable number tandem repeat polymorphism of IL-1RN in bronchopulmonary dysplasia in infants born before 32 weeks of gestation.

Authors:  Dawid Szpecht; Janusz Gadzinowski; Irmina Nowak; Dorothy Cygan; Agnieszka Seremak-Mrozikiewicz; Grażyna Kurzawińska; Dariusz Madajczak; Krzysztof Drews; Marta Szymankiewicz
Journal:  Cent Eur J Immunol       Date:  2017-06-08       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.